OBJECTIVE: Drug-resistance remains a huge problem in the therapy of malignant tumors including non-small cell lung cancer (NSCLC). Several researches have proved that long noncoding RNAs (lncRNAs) contributes to drug-resistance in NSCLC. LncRNA LUCAT1 was explored to identify how it functions in the cisplatin-resistance of NSCLC patients. MATERIALS AND METHODS: Real Time-quantitative Polymerase Chain Reaction … Continue reading Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2